News

A century later, it also is a symbol of environmental sustainability. Today, ZymoGenetics is among an elite group of laboratories around the world that have earned the U.S.

These waivers are applicable to current or pending New Drug Applications (NDAs) as well as successor products, including those with abuse-deterrent properties and associated labeling claims. In connection

Ofatumumab is a monoclonal antibody designed to target the CD20 molecule found on the surface of chronic lymphocytic leukemia (CLL) cells and normal B lymphocytes. The transfer of

NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. The open-label trial will evaluate the safety and clinical effects of NTCELL in patients

Construction has already started and the new Diabetes Research House facility is scheduled to be opened in early 2016. Following completion, the new Diabetes Research House will be

The trial is designed to assess the efficacy and safety of enzalutamide in patients with prostate cancer that has biochemically recurred following definitive local therapy with radical prostatectomy

This commitment from the Gates Foundation also includes additional investments in Affinivax based on the achievement of future success-based milestones. Proceeds from the funding will be used to

ASLAN’s adoption of the industry-leading Medidata Clinical Cloud™ supports the company’s strategy of maximizing the value of its in-licensed drug portfolio by conducting high quality, efficient clinical development

Treatments of other bladder disorders are also covered by the patent, including glycosaminoglycan ("GAG") deficient forms of cystitis or GAG-deficiency, such as, accompanying chronic urinary tract infection, radiation-